论文部分内容阅读
目的探讨复方酪酸杆菌活菌散治疗小儿腹泻病的临床效果。方法将我院收治的110例小儿腹泻患者,随机分为对照组和观察组,两组均给予补液、抗炎、抗病毒、纠正水、电解质紊乱及酸碱平衡等常规对症支持治疗。对照组在常规治疗的基础上加用蒙脱石散治疗,观察组在常规治疗的基础上加用复方酪酸杆菌活菌散治疗。比较两组治疗效果及不良反应发生情况。结果观察组总有效率显著高于对照组,差异有统计学意义(P<0.05)。两组治疗过程中,均未见明显不良反应发生。结论采用复方酪酸杆菌活菌散治疗小儿腹泻,疗效优于蒙脱石散治疗,不良反应少,使用方便,值得临床推广应用。
Objective To investigate the clinical efficacy of compound butyric acid bacteria live bacteria powder in the treatment of infantile diarrhea. Methods A total of 110 cases of infantile diarrhea admitted to our hospital were randomly divided into control group and observation group. Both groups received routine symptomatic supportive treatment such as rehydration, anti-inflammatory, anti-virus, water and electrolyte disturbance and acid-base balance. The control group on the basis of conventional treatment plus montmorillonite treatment, the observation group on the basis of conventional treatment plus compound butyric acid bacilli treatment. Compare the two groups of treatment and adverse reactions. Results The total effective rate of the observation group was significantly higher than that of the control group, the difference was statistically significant (P <0.05). Two groups of treatment, no significant adverse reactions occurred. Conclusion The use of compound butyric acid bacilli in the treatment of children with diarrhea is superior to montmorillonite treatment, with fewer side effects and easy to use, which is worthy of clinical application.